A novel method for estimating the volume of capillary haemangioma to determine response to treatment

Clinical and Experimental Dermatology

Volumn 22, Issue 1, 1997, Pages 20-22

  Dixon, J J ^a   James, D ^b   Fleming, P J ^b   Kennedy, C T C ^b  

^a NORTH BRISTOL NHS TRUST   (United Kingdom)

^b BRISTOL ROYAL HOSPITAL FOR CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; STEROID;

AIRWAY OBSTRUCTION; AMBLYOPIA; ARTICLE; CAPILLARY HEMANGIOMA; CASE REPORT; CRYOPRECIPITATION; DISEASE ASSOCIATION; DISEASE SEVERITY; DOSE RESPONSE; FEMALE; HUMAN; MALE; NEWBORN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; STEROID THERAPY; THROMBOCYTE ACTIVATION; THROMBOCYTE TRANSFUSION;

EID: 0030753410     PISSN: 03076938     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2230.1997.2040617.x     Document Type: Article

References (6)

1. Enjolras O, Riche MC, Merland JJ, Escande JP. Management of alarming haemangiomas in infancy: a review of 25 cases. Paediatr 1990; 85: 491-8.
2. Brand PPP, Lingen RA van, Brus F, Talsma MD, Elzenga NJ. Hypertrophic obstructive cardiomyopathy as a side effect of dexamethasone treatment for bronchopulmonary dysplasia. Acta Paediatr 1993; 82: 614-17.
3. Evans N. Cardiovascular effects of dexamethasone in the preterm infant. Arch Dis Child 1994; 70: F25-F30.
4. Ettlinger JJ, Fleming PJ, Joffe HS, Kennedy CTC. Cavernous haemangioma with Kasabach-Merritt syndrome: treatment with alpha-interferon. J Roy Soc Med 1996; 89: 55-6.
5. Ezekowitz RAB, Mulliken JB, Folkman J. Interferon alpha-2a therapy for life-threatening haemangiomas of infancy. N Engl J Med 1992; 22: 1456-63.
6. Teillac-Hamel D, Prost Y De, Bodemer C et al. Serious childhood angiomas: unsuccessful alpha-2b interferon treatment. A report of 4 cases. Br J Dermatol 1993; 129: 473-6.